Antihypertrophic effects of adiponectin on cardiomyocytes are associated with the inhibition of heparin-binding epidermal growth factor signaling

Biochemical and Biophysical Research Communications

Volumn 393, Issue 3, 2010, Pages 519-525

  Liao, Yulin ^a   Xuan, Wanling ^a   Zhao, Jing ^a   Bin, Jianpin ^a   Zhao, Hui ^b   Asakura, Masanori ^b   Funahashi, Tohru ^c   Takashima, Seiji ^c   Kitakaze, Masafumi ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Heparin binding epidermal growth factor; Mouse; Myocardial hypertrophy

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; BRAIN NATRIURETIC PEPTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR;

ANIMAL CELL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG MECHANISM; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; CARDIOMEGALY; CELL LINE; HEART VENTRICLES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; ORGAN SIZE; RATS; SIGNAL TRANSDUCTION;

MURINAE; MUS; RATTUS;

EID: 77949261582     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.039     Document Type: Article

References (28)

1. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., Kumada M., Sato K., Schiekofer S., Ohashi K., Funahashi T., Colucci W.S., and Walsh K. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 10 (2004) 1384-1389
2. Liao Y., Takashima S., Maeda N., Ouchi N., Komamura K., Shimomura I., Hori M., Matsuzawa Y., Funahashi T., and Kitakaze M. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc. Res. 67 (2005) 705-713
3. Ohara T., Kim J., Asakura M., Asanuma H., Nakatani S., Hashimura K., Kanzaki H., Funahashi T., Tomoike H., and Kitakaze M. Plasma adiponectin is associated with plasma brain natriuretic peptide and cardiac function in healthy subjects. Hypertens. Res. 31 (2008) 825-831
4. Tsukamoto O., Fujita M., Kato M., Yamazaki S., Asano Y., Ogai A., Okazaki H., Asai M., Nagamachi Y., Maeda N., Shintani Y., Minamino T., Asakura M., Kishimoto I., Funahashi T., Tomoike H., and Kitakaze M. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J. Am. Coll. Cardiol. 53 (2009) 2070-2077
5. Karmazyn M., Purdham D.M., Rajapurohitam V., and Zeidan A. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc. Res. 79 (2008) 279-286
6. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
7. Hopkins T.A., Ouchi N., Shibata R., and Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc. Res. 74 (2007) 11-18
8. Frankel D.S., Vasan R.S., D'Agostino Sr. R.B., Benjamin E.J., Levy D., Wang T.J., and Meigs J.B. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J. Am. Coll. Cardiol. 53 (2009) 754-762
9. Fujioka D., Kawabata K., Saito Y., Kobayashi T., Nakamura T., Kodama Y., Takano H., Obata J.E., Kitta Y., Umetani K., and Kugiyama K. Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2409-H2416
10. Hong S.J., Park C.G., Seo H.S., Oh D.J., and Ro Y.M. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press. 13 (2004) 236-242
11. Della Mea P., Lupia M., Bandolin V., Guzzon S., Sonino N., Vettor R., and Fallo F. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am. J. Hypertens. 18 (2005) 30-35
12. Wang Y., Gao E., Tao L., Lau W.B., Yuan Y., Goldstein B.J., Lopez B.L., Christopher T.A., Tian R., Koch W., and Ma X.L. AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin. Circulation 119 (2009) 835-844
13. Skurk C., Wittchen F., Suckau L., Witt H., Noutsias M., Fechner H., Schultheiss H.P., and Poller W. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur. Heart J. 29 (2008) 1168-1180
14. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., and Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8 (2002) 35-40
15. Liao Y., Asakura M., Takashima S., Kato H., Asano Y., Shintani Y., Minamino T., Tomoike H., Hori M., and Kitakaze M. Amlodipine ameliorates myocardial hypertrophy by inhibiting EGFR phosphorylation. Biochem. Biophys. Res. Commun. 327 (2005) 1083-1087
16. Liao Y., Zhao H., Ogai A., Kato H., Asakura M., Kim J., Asanuma H., Minamino T., Takashima S., and Kitakaze M. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation. Hypertens. Res. 31 (2008) 335-344
17. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., and Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002) 731-737
18. Liao Y., Ishikura F., Beppu S., Asakura M., Takashima S., Asanuma H., Sanada S., Kim J., Ogita H., Kuzuya T., Node K., Kitakaze M., and Hori M. Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1703-H1708
19. Ebinc H., Ebinc F.A., Ozkurt Z.N., Dogru M.T., Tulmac M., Yilmaz M., and Caglayan O. Impact of adiponectin on left ventricular mass index in non-complicated obese subjects. Endocr. J. 55 (2008) 523-528
20. Kozakova M., Muscelli E., Flyvbjerg A., Frystyk J., Morizzo C., Palombo C., and Ferrannini E. Adiponectin and left ventricular structure and function in healthy adults. J. Clin. Endocrinol. Metab. 93 (2008) 2811-2818
21. Mitsuhashi H., Yatsuya H., Tamakoshi K., Matsushita K., Otsuka R., Wada K., Sugiura K., Takefuji S., Hotta Y., Kondo T., Murohara T., and Toyoshima H. Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension 49 (2007) 1448-1454
22. Ayerden Ebinc F., Ebinc H., Derici U., Aral A., Aybay C., Tacoy G., Koc E., Mutluay R., Altok Reis K., Erten Y., Arinsoy T., and Sindel S. The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. J. Nephrol. 22 (2009) 216-223
23. Komaba H., Igaki N., Goto S., Yokota K., Takemoto T., Hirosue Y., and Goto T. Adiponectin is associated with brain natriuretic peptide and left ventricular hypertrophy in hemodialysis patients with type 2 diabetes mellitus. Nephron Clin. Pract. 107 (2007) c103-c108
24. Patel J.V., Lim H.S., Dubb K., Hughes E.A., and Lip G.Y. Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension. Ann. Med. 41 (2009) 291-300
25. Arita Y., Kihara S., Ouchi N., Maeda K., Kuriyama H., Okamoto Y., Kumada M., Hotta K., Nishida M., Takahashi M., Nakamura T., Shimomura I., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 (2002) 2893-2898
26. Wang Y., Lam K.S., Xu J.Y., Lu G., Xu L.Y., Cooper G.J., and Xu A. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J. Biol. Chem. 280 (2005) 18341-18347
27. Fayad R., Pini M., Sennello J.A., Cabay R.J., Chan L., Xu A., and Fantuzzi G. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 132 (2007) 601-614
28. Midwinter R.G., Peskin A.V., Vissers M.C., and Winterbourn C.C. Extracellular oxidation by taurine chloramine activates ERK via the epidermal growth factor receptor. J. Biol. Chem. 279 (2004) 32205-32211